Skip to main content
Equibles

HANCOCK WHITNEY CORP

Position in DYAI — Dyadic International Inc

CIK 750577 GULFPORT, MS
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,999
+$888 QoQ
Shares Held
11,111
0.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 39 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HANCOCK WHITNEY CORP holds $38,673,624 across 11 Biotechnology names. DYAI ranks #10 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 330,756 $17,996,433
2 HALO
Halozyme Therapeutics, Inc.
 205,652 $16,096,381
3 JAZZ
Jazz Pharmaceuticals plc
 6,649 $1,602,209
4 INCY
Incyte Corp
 10,836 $1,228,368
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,276 $633,827
6 REGN
Regeneron Pharmaceuticals, Inc.
 792 $493,843
7 HRMY
Harmony Biosciences Holdings, Inc.
 8,677 $315,928
8 INVA
Innoviva, Inc.
 11,967 $271,769

All Filings in DYAI

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,999 11,111
2026-03-31 $9,111 11,111
2025-12-31 $10,444 11,111
2025-09-30 $13,110 11,111
2025-06-30 $10,999 11,111